The global saccharin market size is anticipated to reach US$ 5.9 Billion in 2022 and US$ 13.2 Billion in 2022. It is set to exhibit growth at a CAGR of 8.6% in the forecast period from 2022 to 2032. The rising demand for low calorie sugar substitutes across the globe is projected to spur the demand for saccharin in the upcoming years.
| Report Attribute | Details |
| Saccharin Market Estimated Base Year Value (2021) | US$ 4.7 Billion |
| Saccharin Market Expected Market Value (2022) | US$ 5.9 Billion |
| Saccharin Market Anticipated Forecast Value (2032) | US$ 13.2 Billion |
| Saccharin Market Projected Growth Rate (2022-2032) | 8.6% CAGR |
Saccharin is referred to as an artificial sweetener that is nearly 300–400 times sweeter than sucrose. Its name implies a sugary taste, but it has a metallic after-taste. This strong after-taste is usually masked by blending it with cyclamate.
Saccharin has limited water solubility and is considered to be a heat stable compound. This property can be improved by converting it to its sodium saccharin salt form.
The increasing usage of saccharin to sweeten various products, such as medicines, candies, drinks, and cookies is anticipated to bode well for the global market. It is available in either liquid or granule form. One serving of saccharin provides sweetness comparable to two teaspoons of sugar.
The rising health consciousness among consumers is compelling manufacturers to use saccharin as an ingredient for making various products, such as dessert toppings, baked goods, fruit juice drinks, and cookies. This ingredient has a longer shelf life, as compared to sugar and thus is gaining more popularity in end-use industries.
It is also extensively used in the pharmaceutical industry for the manufacturing of teeth whiteners, mouthwash, cough syrups, and toothpaste. It is also used in the production of vitamin supplements. The rising prevalence of numerous chronic illnesses among people is set to spur the demand for dietary and health supplements, which would propel the saccharin market growth.
Many diet drink manufacturers have shifted towards aspartame as a sweetener owing to the ban on saccharin in the 1970s. Large amounts of saccharin can negatively affect the balance of bacteria present in an individual’s guts. Microbial changes in the intestines can lead to obesity, cancer, and type 2 diabetes. Spurred by the aforementioned factors, the sales of saccharin may decline in the evaluation period.
The increasing awareness about the availability of the product across Canada and the U.S. is estimated to bolster the North America saccharin market share in future years. The surging prevalence of diabetes and hyperglycaemia in this region is another vital factor that is likely to augur well for the regional market.
As per the Centers for Disease Control and Prevention (CDC), in 2018, nearly 34.2 million people of all ages in the U.S. had diabetes. Approximately 34.1 million adults belonging to the age group of 18 years and above were diagnosed with diabetes the same year. These numbers are expected to grow at a fast pace in the assessment period, thereby boosting the North America market.
Increasing awareness about various risks associated with diabetes is compelling people in developing countries to focus more on their dental health. They are also shifting towards weight management plans and this factor is set to spur the Asia Pacific saccharin market growth in the upcoming years.
The surging demand for artificial sweeteners, such as saccharin owing to the increasing prevalence of obesity in India and China is set to augment the growth in Asia Pacific. In addition to that, the rising number of new product launches by key players is expected to drive the regional market.
Some of the renowned companies operating in the global saccharin market include PT Batang Alum Industrie, KISCO (Kyung-In Synthetic Corporation), Jet Chemicals Pvt. Ltd., Spirochem Lifesciences Pvt. Ltd., PMC Specialties Group Inc., Cumberland Packing Corp., Rodals Srl, Van Wankum Ingredients, Muby Chemicals, DK Pharmachem Pvt. Ltd., and Alstercare GmbH among others.
Many companies worldwide are joining hands with educational institutions to conduct exhaustive research and development activities. They are doing so to launch innovative products that can cater to the surging consumer demand.
In January 2022, for instance, the Ohio State University Wexner Medical Center discovered that saccharin did not induce glucose intolerance or change the gut microbiota in healthy adults. The increasing number of such research activities are set to help key players in generating more sales.
| Report Attribute | Details |
| Growth Rate | CAGR of 8.6% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015-2020 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
By Form:
By Type:
By End Use:
By Distribution Channel:
By Region:
The global saccharin market is anticipated to surpass US$ 13.2 Billion in 2032.
North America is set to lead the saccharin market in the forecast period.
PT Batang Alum Industrie, KISCO (Kyung-In Synthetic Corporation), Jet Chemicals Pvt. Ltd., Spirochem Lifesciences Pvt. Ltd., and PMC Specialties Group Inc. are some of the renowned companies in the saccharin market.
Explore Similar Insights
Saccharin Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
